| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes
|
Cangiano, Elisa
|
|
2011
|
|
3 |
p. 189-198
|
artikel
|
| 2 |
Acute Effects of Isosorbide Dinitrate and Nicorandil on the Coronary Slow Flow Phenomenon
|
Sadamatsu, Kenji
|
|
2010
|
|
3 |
p. 203-208
|
artikel
|
| 3 |
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA
|
Do, Thy P.
|
|
2017
|
|
3 |
p. 205-211
|
artikel
|
| 4 |
A Guide to the Management of Blood Pressure in the Diabetic Hypertensive Patient
|
Shammas, Nicolas W.
|
|
2009
|
|
3 |
p. 149-162
|
artikel
|
| 5 |
Alcohol and Cardiovascular Health
|
Sesso, Howard D.
|
|
2001
|
|
3 |
p. 167-172
|
artikel
|
| 6 |
Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study
|
Oh, Pyung Chun
|
|
2016
|
|
3 |
p. 221-228
|
artikel
|
| 7 |
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches
|
Nwanosike, Ezekwesiri Michael
|
|
|
|
3 |
p. 287-299
|
artikel
|
| 8 |
Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects
|
Harada, Akiko
|
|
|
|
3 |
p. 249-258
|
artikel
|
| 9 |
Bosentan
|
Oldfield, Vicki
|
|
2006
|
|
3 |
p. 189-208
|
artikel
|
| 10 |
Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
|
Varjabedian, Leon
|
|
2018
|
|
3 |
p. 181-193
|
artikel
|
| 11 |
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
|
Kow, Chia Siang
|
|
|
|
3 |
p. 217-221
|
artikel
|
| 12 |
Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review
|
Alcocer, Luis
|
|
2016
|
|
3 |
p. 171-182
|
artikel
|
| 13 |
Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021
|
Hao, Jun
|
|
|
|
3 |
p. 301-310
|
artikel
|
| 14 |
Chronic Heart Failure
|
Morrissey, Ryan P.
|
|
2011
|
|
3 |
p. 153-171
|
artikel
|
| 15 |
Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature
|
Nakamura, Junichi
|
|
|
|
3 |
p. 329-338
|
artikel
|
| 16 |
Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease
|
Pirlet, Charles
|
|
|
|
3 |
p. 271-281
|
artikel
|
| 17 |
Clinical Inertia in Poorly Controlled Elderly Hypertensive Patients: A Cross-Sectional Study in Spanish Physicians to Ascertain Reasons for Not Intensifying Treatment
|
Gil-Guillén, Vicente
|
|
2013
|
|
3 |
p. 213-219
|
artikel
|
| 18 |
Clopidogrel
|
Chow, Grant
|
|
2007
|
|
3 |
p. 169-171
|
artikel
|
| 19 |
Cocaine Cardiotoxicity
|
Phillips, Katharine
|
|
2009
|
|
3 |
p. 177-196
|
artikel
|
| 20 |
Combination Therapy in Hypertension: What Are the Best Options According to Clinical Pharmacology Principles and Controlled Clinical Trial Evidence?
|
Taddei, Stefano
|
|
2015
|
|
3 |
p. 185-194
|
artikel
|
| 21 |
Comparison of the Efficacy and Safety of Fixed-Dose Amlodipine/Losartan and Losartan in Hypertensive Patients Inadequately Controlled with Losartan
|
Hong, Bum-Kee
|
|
2012
|
|
3 |
p. 189-195
|
artikel
|
| 22 |
Comparison of Warfarin Requirements in Post-cardiac Surgery Patients: Valve Replacement Versus Non-valve Replacement
|
Olson, Logan M.
|
|
2018
|
|
3 |
p. 223-229
|
artikel
|
| 23 |
Consistency of Extended-Release Niacin/Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups
|
Bays, Harold E.
|
|
2012
|
|
3 |
p. 197-206
|
artikel
|
| 24 |
Correction to: Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
|
Syed, Yahiya Y.
|
|
|
|
3 |
p. 355
|
artikel
|
| 25 |
Cost-Effectiveness Analysis of Cholesterol-Lowering Therapies in Spain
|
Plans-Rubió, Pedro
|
|
2006
|
|
3 |
p. 177-188
|
artikel
|
| 26 |
Cost Effectiveness of Eplerenone in Patients with Chronic Heart Failure
|
Ademi, Zanfina
|
|
2014
|
|
3 |
p. 209-216
|
artikel
|
| 27 |
Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada
|
Rinfret, Stéphane
|
|
2006
|
|
3 |
p. 159-168
|
artikel
|
| 28 |
Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension
|
Ojha, Utkarsh
|
|
|
|
3 |
p. 271-285
|
artikel
|
| 29 |
Dapagliflozin Versus Sacubitril–Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus
|
Hammerman, Ariel
|
|
|
|
3 |
p. 325-331
|
artikel
|
| 30 |
De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials
|
Abdelazeem, Basel
|
|
|
|
3 |
p. 287-298
|
artikel
|
| 31 |
Defining the Place of Ezetimibe/Atorvastatin in the Management of Hyperlipidemia
|
Ferreira, António Miguel
|
|
2016
|
|
3 |
p. 169-181
|
artikel
|
| 32 |
Defining the Role of High-Dose Statins in PCI
|
Guarini, Giacinta
|
|
2013
|
|
3 |
p. 189-197
|
artikel
|
| 33 |
Device Therapy for Heart Failure
|
Shams, Omar F.
|
|
2008
|
|
3 |
p. 147-153
|
artikel
|
| 34 |
Dexmedetomidine Reduces Atrial Fibrillation After Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials
|
Liu, Yang
|
|
|
|
3 |
p. 271-281
|
artikel
|
| 35 |
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
|
Dézsi, Csaba András
|
|
2013
|
|
3 |
p. 167-173
|
artikel
|
| 36 |
Different Effects of Simvastatin and Losartan on Cytokine Levels in Coronary Artery Disease
|
Sadamatsu, Kenji
|
|
2006
|
|
3 |
p. 169-175
|
artikel
|
| 37 |
Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi
|
Saleh, Yehia
|
|
|
|
3 |
p. 231-238
|
artikel
|
| 38 |
Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease
|
Deo, Salil V.
|
|
|
|
3 |
p. 311-321
|
artikel
|
| 39 |
Does a Single-Pill Antihypertensive/Lipid-Lowering Regimen Improve Adherence in US Managed Care Enrollees?
|
Hussein, Mohamed A.
|
|
2010
|
|
3 |
p. 193-202
|
artikel
|
| 40 |
Drug-Eluting Stents for Treatment of Peripheral Artery Disease
|
Abdullah, Kazeen
|
|
2018
|
|
3 |
p. 175-180
|
artikel
|
| 41 |
Economic Evaluation of Enoxaparin for Anticoagulation in Early Cardioversion of Persisting Nonvalvular Atrial Fibrillation
|
Schädlich, Peter K.
|
|
2007
|
|
3 |
p. 199-217
|
artikel
|
| 42 |
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis
|
Alnsasra, Hilmi
|
|
|
|
3 |
p. 323-328
|
artikel
|
| 43 |
Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers
|
Andersson, Tommy
|
|
2014
|
|
3 |
p. 217-227
|
artikel
|
| 44 |
Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions
|
Galo, Jason
|
|
|
|
3 |
p. 267-270
|
artikel
|
| 45 |
Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-Analysis
|
Zheng, Xiao-Dong
|
|
|
|
3 |
p. 321-330
|
artikel
|
| 46 |
Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial
|
Ono, Koh
|
|
|
|
3 |
p. 283-293
|
artikel
|
| 47 |
Effects of Simvastatin and Metformin on Inflammation and Insulin Resistance in Individuals with Mild Metabolic Syndrome
|
Bulcão, Caroline
|
|
2007
|
|
3 |
p. 219-224
|
artikel
|
| 48 |
Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
|
Teo, Yao Neng
|
|
|
|
3 |
p. 299-323
|
artikel
|
| 49 |
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
|
Peyracchia, Mattia
|
|
|
|
3 |
p. 259-269
|
artikel
|
| 50 |
Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia
|
Roth, Eli M.
|
|
2010
|
|
3 |
p. 175-186
|
artikel
|
| 51 |
Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials
|
Li, Haixia
|
|
2016
|
|
3 |
p. 201-219
|
artikel
|
| 52 |
Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies
|
Covic, Adrian
|
|
|
|
3 |
p. 331-347
|
artikel
|
| 53 |
Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels
|
Eraikhuemen, Nathaniel
|
|
|
|
3 |
p. 255-265
|
artikel
|
| 54 |
Endogenous and Exogenous Cardiac Glycosides and their Mechanisms of Action
|
Schoner, Wilhelm
|
|
2007
|
|
3 |
p. 173-189
|
artikel
|
| 55 |
Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity
|
Feng, Jie
|
|
|
|
3 |
p. 231-246
|
artikel
|
| 56 |
Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
|
Price, Laura C.
|
|
2008
|
|
3 |
p. 171-185
|
artikel
|
| 57 |
Endovascular Stents: A Review of Their Use in Peripheral Arterial Disease
|
Kudagi, Vinod S.
|
|
2013
|
|
3 |
p. 199-212
|
artikel
|
| 58 |
Epidemiology and Management of Hypertension in the Hispanic Population
|
Guzman, Nicolas J.
|
|
2012
|
|
3 |
p. 165-178
|
artikel
|
| 59 |
Erratum to: Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)
|
Tóth, Kálmán
|
|
2014
|
|
3 |
p. 239
|
artikel
|
| 60 |
Erratum to: Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice
|
Gonzalez-Quesada, Carlos J.
|
|
2014
|
|
3 |
p. 237
|
artikel
|
| 61 |
Erratum to: Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency
|
Maciejko, James J.
|
|
2017
|
|
3 |
p. 233
|
artikel
|
| 62 |
Etiology and Management of Sustained Ventricular Tachycardia
|
Talwar, K. K.
|
|
2001
|
|
3 |
p. 179-192
|
artikel
|
| 63 |
Expanding Role of Pharmacogenomics in the Management of Cardiovascular Disorders
|
Yip, Vincent Lai Ming
|
|
2013
|
|
3 |
p. 151-162
|
artikel
|
| 64 |
Fixed-Dose Combination Therapy with Statins
|
Hennekens, Charles H.
|
|
2008
|
|
3 |
p. 155-160
|
artikel
|
| 65 |
From the World Literature
|
|
|
2001
|
|
3 |
p. 219-226
|
artikel
|
| 66 |
Gene Therapy for Ischemic Heart Disease
|
Symes, James F.
|
|
2001
|
|
3 |
p. 159-166
|
artikel
|
| 67 |
Heart Rate-Lowering Efficacy and Respiratory Safety of Ivabradine in Patients with Obstructive Airway Disease
|
Majewski, Sebastian
|
|
2012
|
|
3 |
p. 179-188
|
artikel
|
| 68 |
Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart Failure
|
Sargento, Luis
|
|
2014
|
|
3 |
p. 229-235
|
artikel
|
| 69 |
How May Proton Pump Inhibitors Impair Cardiovascular Health?
|
Sukhovershin, Roman A.
|
|
2016
|
|
3 |
p. 153-161
|
artikel
|
| 70 |
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Systematic Review and Meta-analysis of Anticoagulation Strategy
|
Oliveri, Federico
|
|
|
|
3 |
p. 269-276
|
artikel
|
| 71 |
Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study
|
Miyoshi, Toru
|
|
2015
|
|
3 |
p. 213-219
|
artikel
|
| 72 |
Impact of Genetic Polymorphisms on the Efficacy of HMG-CoA Reductase Inhibitors
|
Hutz, Mara H.
|
|
2008
|
|
3 |
p. 161-170
|
artikel
|
| 73 |
Improving the Management of Hypertension by Tackling Awareness, Adherence, and Clinical Inertia: A Symposium Report
|
Pathak, Atul
|
|
|
|
3 |
p. 251-261
|
artikel
|
| 74 |
Inpatient Costs of Major Cardiovascular Events
|
Radensky, Paul W.
|
|
2001
|
|
3 |
p. 205-217
|
artikel
|
| 75 |
Integrated Preclinical Cardiovascular Prevention: A New Paradigm to Face Growing Challenges of Cardiovascular Disease
|
Volpe, Massimo
|
|
2015
|
|
3 |
p. 163-170
|
artikel
|
| 76 |
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
|
Nelson, Winnie W.
|
|
2015
|
|
3 |
p. 205-211
|
artikel
|
| 77 |
Interpreting Cardiovascular Endpoints in Trials of Antihyperglycemic Drugs
|
Chawla, Himika
|
|
2017
|
|
3 |
p. 203-215
|
artikel
|
| 78 |
Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
|
Drozd, Marcin
|
|
2016
|
|
3 |
p. 183-201
|
artikel
|
| 79 |
Is it Time for Single-Pill Combinations in Dyslipidemia?
|
Schiele, François
|
|
|
|
3 |
p. 239-249
|
artikel
|
| 80 |
Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review
|
Gee, Megan E.
|
|
2018
|
|
3 |
p. 195-204
|
artikel
|
| 81 |
Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses
|
Shaya, Fadia Tohme
|
|
|
|
3 |
p. 239-248
|
artikel
|
| 82 |
Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs
|
Zheng, Zi-Heng
|
|
|
|
3 |
p. 299-320
|
artikel
|
| 83 |
Management of Acute Coronary Syndromes in Mexico
|
Leiva-Pons, Jose L.
|
|
2009
|
|
3 |
p. 143-148
|
artikel
|
| 84 |
Management of Hypertension with the Fixed Combination of Perindopril and Amlodipine in Daily Clinical Practice
|
Bahl, Vinay K.
|
|
2009
|
|
3 |
p. 135-142
|
artikel
|
| 85 |
Management of Statin Intolerance in 2018: Still More Questions Than Answers
|
Toth, Peter P.
|
|
2018
|
|
3 |
p. 157-173
|
artikel
|
| 86 |
Management of ST-Elevation Myocardial Infarction
|
Kashani, Amir
|
|
2008
|
|
3 |
p. 187-197
|
artikel
|
| 87 |
Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency
|
Maciejko, James J.
|
|
2017
|
|
3 |
p. 217-231
|
artikel
|
| 88 |
Managing Comorbidities in Patients with Chronic Heart Failure: First, Do No Harm
|
DeJongh, Beth
|
|
2015
|
|
3 |
p. 171-184
|
artikel
|
| 89 |
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation
|
Shahid, Izza
|
|
|
|
3 |
p. 373-376
|
artikel
|
| 90 |
Meta-Analysis of the Cardiovascular Outcomes with Dipeptidyl Peptidase 4 Inhibitors: Validation of the Current FDA Mandate
|
Agarwal, Shikhar
|
|
2014
|
|
3 |
p. 191-207
|
artikel
|
| 91 |
Metabolic Effects of Manidipine
|
Cavalieri, Luca
|
|
2009
|
|
3 |
p. 163-176
|
artikel
|
| 92 |
Neointimal Hyperplasia Inhibition Effect of Angiotensin II Type 1 Receptor Blockers in Patients after Coronary Stent Implantation
|
Kun, Xie
|
|
2011
|
|
3 |
p. 209-213
|
artikel
|
| 93 |
New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations
|
Wang, Yishen
|
|
2014
|
|
3 |
p. 175-189
|
artikel
|
| 94 |
Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events
|
Brinton, Eliot A.
|
|
2011
|
|
3 |
p. 179-187
|
artikel
|
| 95 |
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers
|
Offman, Elliot
|
|
2017
|
|
3 |
p. 251-260
|
artikel
|
| 96 |
Non-Antiarrhythmic Drugs to Prevent Atrial Fibrillation
|
Moro, Concepción
|
|
2010
|
|
3 |
p. 165-173
|
artikel
|
| 97 |
Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals
|
Angeli, Fabio
|
|
|
|
3 |
p. 229-238
|
artikel
|
| 98 |
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
|
Dhamane, Amol D
|
|
|
|
3 |
p. 333-343
|
artikel
|
| 99 |
Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events
|
Ling, Geoffrey
|
|
2009
|
|
3 |
p. 197-209
|
artikel
|
| 100 |
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
|
Kaufmann, Priska
|
|
2015
|
|
3 |
p. 195-203
|
artikel
|
| 101 |
Pharmacologic Treatment of Hypertension in Patients With Chronic Kidney Disease
|
Talreja, Hari
|
|
2013
|
|
3 |
p. 177-188
|
artikel
|
| 102 |
Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US
|
Lyseng-Williamson, Katherine A.
|
|
|
|
3 |
p. 207-216
|
artikel
|
| 103 |
Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US
|
Lyseng-Williamson, Katherine A.
|
|
2012
|
|
3 |
p. 207-216
|
artikel
|
| 104 |
Prognostic Utility of Serum Potassium in Chronic Digoxin Toxicity
|
Manini, Alex F.
|
|
2011
|
|
3 |
p. 173-178
|
artikel
|
| 105 |
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis
|
Zheng, Nan
|
|
|
|
3 |
p. 257-267
|
artikel
|
| 106 |
Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center
|
Nozari, Younes
|
|
2018
|
|
3 |
p. 213-221
|
artikel
|
| 107 |
QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation
|
Egstrup, Kenneth
|
|
2011
|
|
3 |
p. 199-208
|
artikel
|
| 108 |
Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009–2010
|
Castelli, Gregory
|
|
2017
|
|
3 |
p. 243-249
|
artikel
|
| 109 |
Real-World Effectiveness of Ivabradine in Chinese Patients with Chronic Heart Failure: Interim Analysis of the POSITIVE Study
|
Jingmin, Zhou
|
|
|
|
3 |
p. 345-354
|
artikel
|
| 110 |
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
|
Freeman, Mason W.
|
|
|
|
3 |
p. 277-286
|
artikel
|
| 111 |
Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial Disease
|
Deev, Roman
|
|
2017
|
|
3 |
p. 235-242
|
artikel
|
| 112 |
Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding
|
Sheikh-Taha, Marwan
|
|
|
|
3 |
p. 295-299
|
artikel
|
| 113 |
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options
|
Ansell, Jack E.
|
|
2016
|
|
3 |
p. 163-170
|
artikel
|
| 114 |
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study
|
Duraes, Andre Rodrigues
|
|
|
|
3 |
p. 363-371
|
artikel
|
| 115 |
Role of Antihypertensive Drugs in Arterial ‘De-Stiffening’ and Central Pulsatile Hemodynamics
|
Koumaras, Charalambos
|
|
2012
|
|
3 |
p. 143-156
|
artikel
|
| 116 |
Self- versus Conventional Management of Oral Anticoagulant Therapy
|
Christensen, Thomas Decker
|
|
2007
|
|
3 |
p. 191-197
|
artikel
|
| 117 |
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness
|
Cavallari, Ilaria
|
|
|
|
3 |
p. 263-270
|
artikel
|
| 118 |
Statins and Aspirin: Do They Really Work in Women?
|
Desai, Hemal
|
|
2015
|
|
3 |
p. 151-162
|
artikel
|
| 119 |
Statins and the Reduction of Sudden Cardiac Death
|
Beri, Abhimanyu
|
|
2010
|
|
3 |
p. 155-164
|
artikel
|
| 120 |
Statin Utilization Patterns for the Primary Prevention of Cardiovascular Events
|
Lee, Vivian W. Y.
|
|
2008
|
|
3 |
p. 199-205
|
artikel
|
| 121 |
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
|
Alamneh, Endalkachew A.
|
|
2016
|
|
3 |
p. 183-200
|
artikel
|
| 122 |
Systematic Review of the Efficacy and Safety of Perhexiline in the Treatment of Ischemic Heart Disease
|
Killalea, Sheila M.
|
|
2001
|
|
3 |
p. 193-204
|
artikel
|
| 123 |
67th Annual Scientific Sessions of the American College of Cardiology: 10–12 March 2018; Orlando, FL, USA
|
Prakash, Amitabh
|
|
2018
|
|
3 |
p. 245-248
|
artikel
|
| 124 |
66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA
|
Prakash, Amitabh
|
|
2017
|
|
3 |
p. 261-264
|
artikel
|
| 125 |
The Authors’ Reply
|
Friend, Amy S.
|
|
2009
|
|
3 |
p. 213
|
artikel
|
| 126 |
The Effect of Antihypertensive Agents on New-Onset Diabetes Mellitus
|
Aksnes, Tonje Amb
|
|
2006
|
|
3 |
p. 139-147
|
artikel
|
| 127 |
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations
|
Ashton, Veronica
|
|
|
|
3 |
p. 283-297
|
artikel
|
| 128 |
The Potential for Interaction between Warfarin and Coprescribed Medication
|
Snaith, Ailsa
|
|
2008
|
|
3 |
p. 207-212
|
artikel
|
| 129 |
Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
|
Fisk, Marie
|
|
2014
|
|
3 |
p. 155-165
|
artikel
|
| 130 |
Therapeutic Potential of Terminalia Arjuna in Cardiovascular Disorders
|
Maulik, Subir K.
|
|
2012
|
|
3 |
p. 157-163
|
artikel
|
| 131 |
The Restricted Mean Survival Time as a Tool for Ranking Comparative Outcomes in a Narrative Review that Evaluates a Network of Randomized Trials: An Example Based on PCSK9 Inhibitors
|
Messori, Andrea
|
|
|
|
3 |
p. 349-354
|
artikel
|
| 132 |
The Risk for Significant Creatine Kinase Elevation with Statins
|
Stolcpart, Ryan S.
|
|
2010
|
|
3 |
p. 187-192
|
artikel
|
| 133 |
The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease
|
Funder, John W.
|
|
2007
|
|
3 |
p. 151-157
|
artikel
|
| 134 |
The Role of Clopidogrel in Revascularized and Nonrevascularized Patients with Acute Coronary Syndromes
|
Collins, J. Stewart
|
|
2007
|
|
3 |
p. 159-168
|
artikel
|
| 135 |
The Role of Oral Antiplatelet Agents in Atherothrombotic Disease
|
Ferguson, James J.
|
|
2006
|
|
3 |
p. 149-157
|
artikel
|
| 136 |
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia
|
Farnier, Michel
|
|
2011
|
|
3 |
p. 145-152
|
artikel
|
| 137 |
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
|
Helfer, Hélène
|
|
|
|
3 |
p. 223-228
|
artikel
|
| 138 |
Treatment of Hypertension in Obese Patients
|
Kidambi, Srividya
|
|
2013
|
|
3 |
p. 163-175
|
artikel
|
| 139 |
Treatment with Statins in High-Risk Patients
|
Thadani, Udho
|
|
2009
|
|
3 |
p. 211-212
|
artikel
|
| 140 |
Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease
|
Volkl, Albert A.
|
|
|
|
3 |
p. 247-255
|
artikel
|
| 141 |
Use of Calcium Channel Blockers in Cardiovascular Risk Reduction
|
Alcocer, Luis
|
|
2010
|
|
3 |
p. 143-154
|
artikel
|
| 142 |
Warfarin Safety: A Cross-Sectional Study of the Factors Associated with the Consumption of Medicinal Plants in a Brazilian Anticoagulation Clinic
|
Leite, Paula Mendonça
|
|
2018
|
|
3 |
p. 231-243
|
artikel
|
| 143 |
Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
|
Elsamadisi, Pansy
|
|
|
|
3 |
p. 355-361
|
artikel
|
| 144 |
What is the Optimal Blood Pressure in Patients with Diabetes Mellitus?
|
Nilsson, Peter
|
|
2001
|
|
3 |
p. 173-177
|
artikel
|
Tijdschrift beschrijving